- Home
- Equities - Stocks - Shares
- Company Press Releases
- Observe Medical ASA: Key Information Relating To Share Reverse Split
Observe Medical ASA: Key information relating to share reverse split
17 Dec 2024 13:29 CET
Issuer
Observe Medical ASA
Date on which the corporate action was made public: 17 December 2024.
Reverse split ratio: 15 old shares give 1 new share.
Last day including right: To be decided by the board of directors (subject to
approval by the extraordinary general meeting).
Ex-date: To be decided by the board of directors (subject to approval by the
extraordinary general meeting).
Record date: To be decided by the board of directors (subject to approval by the
extraordinary general meeting).
Date of approval: 7 January 2025.
Other information (optional): Reference is made to the notice of the
extraordinary general meeting of Observe Medical ASA to be held on 7 January
2025. The board of directors proposes that the general meeting resolves a 15:1
share consolidation (reverse share split), so that 15 shares are consolidated
into 1 share. A new ISIN number will be issued for the new shares, and a key
information announcement will be published in connection therewith. Further
information will be provided in due course.
This information is published in accordance with the requirements of the
Continuing Obligations for companies listed on the Oslo Stock Exchange and
Euronext Expand.
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical:
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialisation of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.
More information:
Access the news on Oslo Bors NewsWeb site
Source
Observe Medical ASA
Provider
Oslo Børs Newspoint
Company Name
OBSERVE MEDICAL
ISIN
NO0010865009
Symbol
OBSRV
Market
Euronext Expand